| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4f8755c361b70eb6af66fd6a114e590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate |
2014-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56074bb35cbc3f844861f7b0bd16e57c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdcac79295bdfc1b16e27a4381f9f91e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68ef65c8c2a4337eded2dea2fa968802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4930e3b60993e0f8932cb2bfee647927 |
| publicationDate |
2014-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014196347-A |
| titleOfInvention |
Nanoparticles containing peptides, vectors containing them, and pharmaceutical uses of said nanoparticles and said vectors |
| abstract |
The present invention relates to nanoparticles comprising peptides and carriers comprising said nanoparticles, with or without a dispersant. The invention also relates to the pharmaceutical and / or therapeutic use of said vectors, in particular for the treatment of systemic lupus erythematosus. The invention relates to a nanoparticle comprising a matrix comprising at least one polysaccharide and a peptide P140 having the sequence of SEQ ID NO: 1 or an analogue thereof, wherein said polysaccharide is preferably one or more The present invention relates to nanoparticles that are polysaccharides having negatively charged functional groups. The invention also relates to a carrier for oral administration comprising a carrier comprising at least one nanoparticle as defined above, with or without a dispersant. [Selection figure] None |
| priorityDate |
2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |